ES554864A0 - Procedimiento para la preparacion de un conjugado bacteriano - Google Patents

Procedimiento para la preparacion de un conjugado bacteriano

Info

Publication number
ES554864A0
ES554864A0 ES554864A ES554864A ES554864A0 ES 554864 A0 ES554864 A0 ES 554864A0 ES 554864 A ES554864 A ES 554864A ES 554864 A ES554864 A ES 554864A ES 554864 A0 ES554864 A0 ES 554864A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
conjugate
bacterial
bacterial conjugate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES554864A
Other languages
English (en)
Other versions
ES8704350A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Université Catholique de Louvain
Original Assignee
Université Catholique de Louvain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Université Catholique de Louvain filed Critical Université Catholique de Louvain
Publication of ES8704350A1 publication Critical patent/ES8704350A1/es
Publication of ES554864A0 publication Critical patent/ES554864A0/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ES554864A 1985-05-14 1986-05-12 Procedimiento para la preparacion de un conjugado bacteriano Expired ES8704350A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8507315A FR2581877B1 (fr) 1985-05-14 1985-05-14 Conjugue constitue d'une adhesine de paroi de s. mutans, de nature proteique et d'un polysaccharide de s. mutans, sa preparation et son utilisation notamment dans des vaccins anti-caries

Publications (2)

Publication Number Publication Date
ES8704350A1 ES8704350A1 (es) 1987-04-16
ES554864A0 true ES554864A0 (es) 1987-04-16

Family

ID=9319266

Family Applications (1)

Application Number Title Priority Date Filing Date
ES554864A Expired ES8704350A1 (es) 1985-05-14 1986-05-12 Procedimiento para la preparacion de un conjugado bacteriano

Country Status (10)

Country Link
US (1) US4789735A (es)
EP (1) EP0206852A1 (es)
JP (1) JPS6226236A (es)
AU (1) AU598190B2 (es)
DK (1) DK221586A (es)
ES (1) ES8704350A1 (es)
FR (1) FR2581877B1 (es)
GR (1) GR861242B (es)
PT (1) PT82575B (es)
ZA (1) ZA863572B (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5916588A (en) * 1984-04-12 1999-06-29 The Liposome Company, Inc. Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
US6090406A (en) * 1984-04-12 2000-07-18 The Liposome Company, Inc. Potentiation of immune responses with liposomal adjuvants
US5583112A (en) * 1987-05-29 1996-12-10 Cambridge Biotech Corporation Saponin-antigen conjugates and the use thereof
US5472696A (en) * 1988-02-26 1995-12-05 Univ. Of Florida Research Foundation, Inc. Antigen of group B streptococci
US5055455A (en) * 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
EP0380084A3 (en) * 1989-01-27 1991-03-13 The Biomembrane Institute Method for the inhibition of cell-cell and cell substratum interactions by the blocking of carbohydrate-carbohydrate interactions
US5190746A (en) * 1989-05-10 1993-03-02 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Plaque inhibiting oligosaccharide
US5071977A (en) * 1989-05-10 1991-12-10 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Plaque inhibiting oligosaccharide
US5002759A (en) * 1989-07-25 1991-03-26 Colgate-Palmolive Company Oligosaccharide inhibition of Streptococcus pyogenes adhesion
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
US5202113A (en) * 1990-04-30 1993-04-13 The United States Of America As Represented By The Department Of Health And Human Services Plaque-inhibiting protein from bacteroides loeschei and methods for using the same
NZ239643A (en) * 1990-09-17 1996-05-28 North American Vaccine Inc Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
US7279162B1 (en) * 1990-10-22 2007-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
US5422427A (en) * 1991-09-17 1995-06-06 The United States Of America As Represented By The United States Department Of Health And Human Services Pneumococcal fimbrial protein A
US6312944B1 (en) 1991-11-14 2001-11-06 The United States Of America As Represented By The Department Of Health And Human Services Pneumococcal fimbrial protein A
US5854416A (en) 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
WO1993010238A1 (en) * 1991-11-14 1993-05-27 The Government Of The United States Of America As Represented By The Department Of Health And Human Services Pneumococcal fimbrial protein a vaccines
ZA937034B (en) * 1992-09-24 1995-06-23 Brigham & Womens Hospital Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
DE69330464T2 (de) * 1992-09-24 2001-11-08 Brigham And Women's Hospital, Boston Gruppe b streptococcus typ ii und typ v polysaccharid-protein konjugate als impfstoffe
US6284884B1 (en) 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
WO1997016730A1 (en) 1995-11-03 1997-05-09 Stephen Holland Method of diagnosing crohn's disease
US5882871A (en) * 1996-09-24 1999-03-16 Smithkline Beecham Corporation Saliva binding protein
US6426074B1 (en) 1997-03-19 2002-07-30 The Brigham And Women's Hospital Inc. Group B Streptococcus vaccine
US6610293B1 (en) 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
DE69936296D1 (de) 1998-04-10 2007-07-26 Andrew Lees Konjugat-impfstoffe zur vorbeugung der zahnkaries
US7250494B2 (en) * 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
US6803448B1 (en) * 1998-07-22 2004-10-12 Vanderbilt University GBS toxin receptor
US8609614B2 (en) 1998-07-22 2013-12-17 Vanderbilt University GBS toxin receptor compositions and methods of use
WO2003015815A1 (en) * 2001-08-21 2003-02-27 The Brigham And Women's Hospital, Inc. Improved conjugate vaccines
US20040096461A1 (en) * 2002-07-30 2004-05-20 Baxter Healthcare Corporation Chimeric multivalent polysaccharide conjugate vaccines
WO2004043405A2 (en) 2002-11-12 2004-05-27 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
AU2003290867A1 (en) 2002-11-12 2004-06-03 The Brigham And Women's Hospital, Inc. Methods and products for treating staphylococcal infections
GB0313644D0 (en) * 2003-06-12 2003-07-16 Univ Bristol Inhibition of infection
WO2005044861A1 (en) * 2003-10-31 2005-05-19 Wyeth Holdings Corporation Polysaccharides of helicobacter pylori
PL1745075T3 (pl) 2004-04-21 2013-09-30 Brigham & Womens Hospital Inc Peptydy wiążące poli-N-acetyloglukozaminę (PNAG/DPNAG) i sposoby ich zastosowania
MX2007005202A (es) 2004-11-01 2007-07-09 Brigham & Womens Hospital Polisacaridos de estreptococo modificados y usos de los mismos.
CN102159540B (zh) 2008-07-21 2015-08-12 布赖汉姆妇女医院 与合成的β-1,6葡糖胺寡糖相关的方法和组合物
US9050283B2 (en) 2009-01-16 2015-06-09 University Of Maryland, Baltimore Broad spectrum vaccine against non-typhoidal Salmonella
US12397014B2 (en) 2019-02-05 2025-08-26 The Brigham And Women's Hospital, Inc. Polysaccharide compositions for use in treating filariasis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA794413B (en) * 1978-09-01 1980-08-27 Us Government Protection against dental caries
DE3263103D1 (en) * 1981-06-19 1985-05-23 Secr Social Service Brit Protection against dental caries
JPS59151847A (ja) * 1982-03-25 1984-08-30 Kitasato Inst:The 非う蝕性組成物および飲料
US4619828A (en) * 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
GB8303994D0 (en) * 1983-02-14 1983-03-16 Council Of Governors Of United Antigenic materials
US4693888A (en) * 1983-08-11 1987-09-15 Lion Corporation Caries-preventive composition
NZ214503A (en) * 1984-12-20 1990-02-26 Merck & Co Inc Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates

Also Published As

Publication number Publication date
FR2581877A1 (fr) 1986-11-21
JPS6226236A (ja) 1987-02-04
ZA863572B (en) 1987-07-29
AU598190B2 (en) 1990-06-21
FR2581877B1 (fr) 1987-12-18
ES8704350A1 (es) 1987-04-16
PT82575A (fr) 1986-06-01
DK221586D0 (da) 1986-05-13
GR861242B (en) 1986-08-27
AU5741286A (en) 1986-12-18
DK221586A (da) 1986-11-15
US4789735A (en) 1988-12-06
PT82575B (fr) 1987-09-22
EP0206852A1 (fr) 1986-12-30

Similar Documents

Publication Publication Date Title
ES551249A0 (es) Un procedimiento para la preparacion de peptidilaminodioles.
ES554405A0 (es) Un procedimiento para la preparacion de derivados de aza-indol.
ES557743A0 (es) Un procedimiento para la preparacion de nuevas piranopiridinas
ES553044A0 (es) Un procedimiento para la preparacion de nuevos derivados de fenoxialquilaminopirimidina.
ES556738A0 (es) Un procedimiento para la preparacion de nuevos piridazinaminas.
MX162864B (es) Procedimiento para la preparacion de 2,2,6,6-tetraalquil-4-piperidilaminas
ES554983A0 (es) Un procedimiento para la preparacion de silileteres.
ES552189A0 (es) Un procedimiento para la preparacion de derivados de piridimilmidazolidiona.
ES553415A0 (es) Un procedimiento para la preparacion de derivados de ariletanolamina.
ES557413A0 (es) Un procedimiento para la preparacion de un polialquenoilisocianato
ES554286A0 (es) Un procedimiento para la preparacion de nuevos derivados glicopepticos
ES557772A0 (es) Un procedimiento para la preparacion de epipodofilotoxina
ES554661A0 (es) Un procedimiento para la preparacion de un hidralizado proteico.
ES557427A0 (es) Un procedimiento para la preparacion de tetrahidroimidazoquinazolinonas
ES557019A0 (es) Un procedimiento para la preparacion de derivados aminicos
ES553703A0 (es) Un procedimiento para la preparacion de vesiculas de fosfoliptidos.
ES541277A0 (es) Procedimiento para la preparacion de un nuevo derivado de lafructosa
MX162939B (es) Procedimiento mejorado para la preparacion de monoterbutiltolueno-diamina
ES554469A0 (es) Un procedimiento para la preparacion de derivados de mitomicina c
ES556768A0 (es) Un procedimiento para la preparacion de aminoalquil secocantinas.
ES555670A0 (es) Un procedimiento para la preparacion de hexahidroarilquinolizinas sustituidas.
ES555109A0 (es) Un procedimiento para la preparacion de nuevos derivados de propanodiona.
ES556807A0 (es) Un procedimiento para la preparacion de nuevos 11-metileno-esteroides.
ES553877A0 (es) Un procedimiento para la preparacion de un derivado de ciclopentadieno polimerico.
ES553875A0 (es) Un procedimiento para la preparacion de derivados de beurazepina.